Drug intelligence / Profile preview

N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide

Development stage: Unknown
Modality: Small Molecules

Overview

N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide is a small molecule experimental compound belonging to the benzamide class of organic compounds. It contains a carboxamido substituent and has the molecular formula C16H16N4O with an average molecular weight of approximately 280.32 g/mol. This compound is not approved for clinical use and has no recorded indications or marketed brand names. There is no publicly available detailed information on its mechanism of action, developer, or manufacturer, and it appears to be primarily used in research contexts.

Other names: N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide

Targets

NOS3 (eNOS)

Beyond the preview

Go deeper on N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-[2-(6-amino-4-methylpyridin-2-yl)ethyl]-4-cyanobenzamide.

Explore the full profile